HF
REGN icon

Hoxton Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Hoxton Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$11K Hold
30
– – 0.01% 244
2015
Q4 		$16K Hold
30
– – 0.01% 210
2015
Q3 		$14K Buy
+30
New +$16.1K 0.01% 210

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hoxton Financial's REGN Position: Q1 2016 in Review

Hoxton Financial held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2016 at 30 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #244.

Hoxton Financial first reported a position in REGN in Q3 2015 and has held it in 3 quarters since. The position peaked at $16K in Q4 2015. 550 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

  • Hoxton Financial held 30 shares of Regeneron Pharmaceuticals worth $11K as of Q1 2016.
  • Hoxton Financial left its Regeneron Pharmaceuticals share count unchanged in Q1 2016.
  • Regeneron Pharmaceuticals made up 0.01% of Hoxton Financial's portfolio in Q1 2016, its #244 holding.
  • Hoxton Financial first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 3 quarters since.
  • Hoxton Financial's Regeneron Pharmaceuticals position peaked at $16K in Q4 2015.
  • 550 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.